Blood markers in preterm babies with breathing problems
Part of Hormones & metabolism, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at two substances in the blood (endocan and copeptin) to see if they can help doctors understand breathing problems in premature babies. It may lead to better ways to care for these infants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born early (preterm).
- Your baby was born between 28 and 36 weeks of pregnancy.
- Your baby has respiratory distress syndrome (a common breathing problem in preemies).
- Your baby does not have certain serious conditions (like growth problems in the womb, brain injury, or birth defects).
- You did not have diabetes or an infection of the membranes during pregnancy (chorioamnionitis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving L-carnitine, a nutrient that helps cells make energy, to premature newborns with respiratory distress syndrome (RDS) can improve their health. It may help their bodies cope better in the NICU.
This study tests a simple non-invasive score that uses blood flow in muscles to predict if a newborn has or will develop high inflammation levels (C-reactive protein). It may help doctors start treatment earlier in babies with breathing problems.
This study tests a way to prevent chronic lung disease in very premature babies. It is for babies born before 32 weeks who needed breathing help right after birth.
This study looks at a special blood marker in full-term newborns who had brain injury from lack of oxygen during birth. It aims to help doctors better understand and treat this condition.
This study uses lung ultrasound to see if it can predict which late preterm babies (born 34–36 weeks) might have trouble breathing after birth. The goal is to find these babies early so they can get the right care sooner.
This study looks at early signs of infection in premature babies. It checks two substances in the baby's blood (IL-6 and PCT) within the first 12 hours after birth to see if they can help detect sepsis early. Participation involves collecting a small extra blood sample during routine tests.
Hear when a new Copeptin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.